Every year, October is observed as World Down Syndrome awareness month, aiming to aware the general population about Down syndrome. It is a genetic disorder, also known as Trisomy 21 that is caused by the presence of partial or complete of a third copy of a chromosome 21. The early symptoms of Down syndrome are delayed physical growth, intellectual disability, characteristic facial features.
DelveInsight Blog
Related Article
Annovis announces IPO results; Conatus merges with Histogen; Novartis discontinues its generic journey
A Philadelphia-based pharmaceutical, Annovis Bio, has raised USD12 million by listing its 2 million shares at USD 6 each. The company has managed to net USD 2 million more by offering 40% more shares. The company plans to use the funds raised to address the unmet needs in the Alzheimer’s disease market...
Find MoreComplex Regional Pain Syndrome Upcoming Therapies
As per DelveInsight’s estimates, total Complex Regional Pain Syndrome cases in the 7MM were found to be 253,603 in 2017. The United States accounted for the highest CRPS prevalent population with 179,441 cases. In terms of European countries, Germany recorded for the highest Complex regional pain syndrome preva...
Find MoreIs Air Pollution a driver in COPD Treatment Market?
Levels of air pollution have risen dramatically over the past years due to increasing outdoor human activities such as industrialization, urbanization and indoor activities like burning of solid fuels, coal, etc. This has contaminated the air we breathe with several harmful substances such as Sulfur dioxide (SO2), ...
Find MoreEditor's Pick
Newsletter/Whitepaper
Recent Article
ASCO Conference 2023
The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.